Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lorcaserin (belviq) (1 trial)
Cardiovascular Diseases (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Overweight (Phase 4)
Trials (1 total)
Trial APIs (1 total)